Sequencing study of NBV-MB control group and MENK-NBV-MB group

RAW264.7 cells were divided into NBV-MB control group and MENK-NBV-MB group. Macrophages infected with NBV-MB were treated with MENK prophylactic intervention. The purpose of this study was to explore the immunological mechanism of MENK regulation of macrophages against NBV-MB, provide data support for MENK to become a new drug or vaccine adjuvant for NBV, and provide new ideas for clinical reovirus prevention and treatment.